Presentation by Sid Barritt is Director in the UNC Liver Center at The University of North Carolina, USA

Non-invasive diagnosis and assessment of NASH in real world clinical practice

Share this article:

How do clinicians assess the severity of NASH in the real-world and are they meaningfull?

NAFLD is a global disease that is highly prevalent and increasing in incidence. While liver histology currently remains the referent standard for the diagnosis and assessment of disease severity in NAFLD, liver biopsy has limitations and is not a practical tool for managing NAFLD in real world clinical practice. Fortunately, there are multiple non-invasive tests (NITs) ranging from clinical prediction scores, to point of care imaging, to magnetic resonance based technologies that can reliably aid in the diagnosis and assessment of NAFLD. psychological factors